Follicle-stimulating hormone (FSH)

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, American Hospital 2 Kosovo

Conditions

Embryo TransferInfertility, FemaleLuteal Hormone Supplementation in In-vitro Fertilization

Phase 3

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

CompletedNCT01863680

Merck KGaA, Darmstadt, GermanyEmbryo Transfer, Luteal Hormone Supplementation in In-vitro Fertilization

Start: 2013-07-31End: 2014-10-31Updated: 2015-12-21

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Not yet recruitingNCT07346235

American Hospital 2 KosovoInfertility, Female

Start: 2026-03-01End: 2029-01-15Target: 440Updated: 2026-01-16